You may find more results for this query on our sister sites: GenomeWeb and 360Dx.
NEW YORK – Rutherford, New Jersey-based Cancer Genetics said on Monday that it will acquire all outstanding capital stock of organoid startup Stemonix in exchange for a number of shares of its common stock.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?Register for Free.